Compounds and methods for inhibiting EMT pathways to treat cancer, organ fibrosis and metabolic disorders
US12297176B2 · kind B2 · utility
0Cited by
2References
18Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Jun 25, 2021 |
| Grant date | May 13, 2025 |
| Priority date | — |
| Expiry date | Nov 21, 2043 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D409/06
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
A compound, or a pharmaceutically acceptable salt or isomer thereof, of Formula I:
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.